Joseph M Beckham, MD | |
2000 E Lamar Blvd, Suite 400, Arlington, TX 76006-7346 | |
(817) 861-3994 | |
(817) 861-3926 |
Full Name | Joseph M Beckham |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 20 Years |
Location | 2000 E Lamar Blvd, Arlington, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1891906806 | NPI | - | NPPES |
M9153 | Other | TX | TEXAS STATE MEDICAL LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | M9153 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Baylor Scott & White All Saints Medical Center Fort Worth | Fort worth, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Northstar Anesthesia Iii Pa | 0042630501 | 335 |
News Archive
A research team at the Swedish medical university Karolinska Institutet has shown for the time that microRNA, small RNA molecules, may play an important role in the development of inflammatory skin diseases such as psoriasis and atopic eczema.
Cancer cells undergo extensive genetic alterations as they grow and spread through the body. Some of these mutations, known as "drivers," help spur cells to grow out of control, while others ("passengers") are merely along for the ride.
Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term; however, the longer term case burden and the potential for evolution of viral ‘escape' from immunity will depend on the robustness of immune responses generated by natural infections and one or two vaccine doses, according to a study from McGill University and Princeton University published today in Science.
The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine.
› Verified 9 days ago
Entity Name | Northstar Anesthesia Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912978610 PECOS PAC ID: 7315907128 Enrollment ID: O20041015000685 |
News Archive
A research team at the Swedish medical university Karolinska Institutet has shown for the time that microRNA, small RNA molecules, may play an important role in the development of inflammatory skin diseases such as psoriasis and atopic eczema.
Cancer cells undergo extensive genetic alterations as they grow and spread through the body. Some of these mutations, known as "drivers," help spur cells to grow out of control, while others ("passengers") are merely along for the ride.
Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term; however, the longer term case burden and the potential for evolution of viral ‘escape' from immunity will depend on the robustness of immune responses generated by natural infections and one or two vaccine doses, according to a study from McGill University and Princeton University published today in Science.
The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine.
› Verified 9 days ago
Entity Name | Northstar Anesthesia Ii Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477066405 PECOS PAC ID: 2365701737 Enrollment ID: O20180110000102 |
News Archive
A research team at the Swedish medical university Karolinska Institutet has shown for the time that microRNA, small RNA molecules, may play an important role in the development of inflammatory skin diseases such as psoriasis and atopic eczema.
Cancer cells undergo extensive genetic alterations as they grow and spread through the body. Some of these mutations, known as "drivers," help spur cells to grow out of control, while others ("passengers") are merely along for the ride.
Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term; however, the longer term case burden and the potential for evolution of viral ‘escape' from immunity will depend on the robustness of immune responses generated by natural infections and one or two vaccine doses, according to a study from McGill University and Princeton University published today in Science.
The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine.
› Verified 9 days ago
Entity Name | Northstar Anesthesia Iii Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356968952 PECOS PAC ID: 0042630501 Enrollment ID: O20201022000080 |
News Archive
A research team at the Swedish medical university Karolinska Institutet has shown for the time that microRNA, small RNA molecules, may play an important role in the development of inflammatory skin diseases such as psoriasis and atopic eczema.
Cancer cells undergo extensive genetic alterations as they grow and spread through the body. Some of these mutations, known as "drivers," help spur cells to grow out of control, while others ("passengers") are merely along for the ride.
Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term; however, the longer term case burden and the potential for evolution of viral ‘escape' from immunity will depend on the robustness of immune responses generated by natural infections and one or two vaccine doses, according to a study from McGill University and Princeton University published today in Science.
The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Joseph M Beckham, MD 2000 E Lamar Blvd, Suite 400, Arlington, TX 76006-7346 Ph: (817) 861-3994 | Joseph M Beckham, MD 2000 E Lamar Blvd, Suite 400, Arlington, TX 76006-7346 Ph: (817) 861-3994 |
News Archive
A research team at the Swedish medical university Karolinska Institutet has shown for the time that microRNA, small RNA molecules, may play an important role in the development of inflammatory skin diseases such as psoriasis and atopic eczema.
Cancer cells undergo extensive genetic alterations as they grow and spread through the body. Some of these mutations, known as "drivers," help spur cells to grow out of control, while others ("passengers") are merely along for the ride.
Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term; however, the longer term case burden and the potential for evolution of viral ‘escape' from immunity will depend on the robustness of immune responses generated by natural infections and one or two vaccine doses, according to a study from McGill University and Princeton University published today in Science.
The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine.
› Verified 9 days ago
Don Escarzega-phan, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1119 W Randol Mill Rd, Arlington, TX 76012 Phone: 817-860-2700 Fax: 817-860-2704 | |
Lakiesha Kitchen Crawford, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 400 W Arbrook Blvd, Ste 130, Arlington, TX 76014 Phone: 855-549-7246 Fax: 817-803-4125 | |
Marc Galland, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 700 Highlander Blvd Ste 415, Arlington, TX 76015 Phone: 817-516-8811 Fax: 817-516-8444 | |
Jason Matthew Voigt, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2000 East Lamar Blvd, Arlington, TX 76006 Phone: 214-207-0862 | |
Felicia Mcleod Abram, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1903 Autry Ct, Arlington, TX 76017 Phone: 817-417-5688 Fax: 817-290-0508 | |
Dr. Charles Creed Coffee, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2000 E. Lamar, 400, Arlington, TX 76006 Phone: 888-804-3000 Fax: 817-334-0235 | |
Dr. Philip W. Eichenholz, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2000 E. Lamar, 400, Arlington, TX 76006 Phone: 888-804-3000 Fax: 817-877-0350 |